Eitan Rubin logo Ben-Gurion University of the Negev logo

Eitan Rubin

Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head, WIN IT Platform


Holds a PhD in Plant Sciences from the Weizmann Institute of Science. Works as a bioinformatician since 1993, first as a PhD student at W.I.S, than as a research scientist in Compugen Ltd., Head of Bioinformaitcs and W.I.S, Head of Bioinformatics at Harvard University, and since 2005, a research scientist (senior lecturer) in the Faculty of Health Sciences, Ben-Gurion University of the Negev.
Since 2005, Dr. Rubin’s work is focusing on precision medicine, first focusing on classical laboratory tests (e.g. Platelet Count), and more recently concentrating the entire lab’s effort on precision cancer medicine. Dr Rubin is part of the WINTHER consortium, and was recently requested to manage the IT infrastructure of the next generation of PCM trials initiated by the WIN Consortium.


Why WIN

Cancer research has become the first line of Precision Medicine; WIN opens a way for me to become a part of a medical revolution.

Eitan Rubin logo

Eitan Rubin

Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head, WIN IT Platform


Ben-Gurion University of the Negev logo

Holds a PhD in Plant Sciences from the Weizmann Institute of Science. Works as a bioinformatician since 1993, first as a PhD student at W.I.S, than as a research scientist in Compugen Ltd., Head of Bioinformaitcs and W.I.S, Head of Bioinformatics at Harvard University, and since 2005, a research scientist (senior lecturer) in the Faculty of Health Sciences, Ben-Gurion University of the Negev.
Since 2005, Dr. Rubin’s work is focusing on precision medicine, first focusing on classical laboratory tests (e.g. Platelet Count), and more recently concentrating the entire lab’s effort on precision cancer medicine. Dr Rubin is part of the WINTHER consortium, and was recently requested to manage the IT infrastructure of the next generation of PCM trials initiated by the WIN Consortium.


Why WIN

Cancer research has become the first line of Precision Medicine; WIN opens a way for me to become a part of a medical revolution.